AbCellera Biologics Inc.

ABCL

Exchange: Nasdaq
Industry: Pharmaceutical Preparations
SEC CIK: 0001703057

SEC filings (opens in a new tab)

In the last 90 days, AbCellera Biologics Inc. insiders filed 4 open-market purchases and 0 sales; 150 institutions reported holding it in 13F filings for Q2 2026, worth $908.8M in total; no superinvestor holds it.

Q1 2022 vs. Q4 2021

How the institutions holding AbCellera Biologics Inc. changed between Q4 2021 and Q1 2022.

All holders in Q1 2022 All holders in Q4 2021

13F holders of ABCL: Q4 2021 compared with Q1 2022
Measure	Q4 2021	Of which not filed for Q1 2022	Q1 2022	Change
Holders	124	1	130	+7
Shares	114.5M	100	113.5M	−1.05M (−0.9%)
Value	$1.63B	$1.00K	$1.10B	−$524.1M (−32.2%)

1 institution that held it in Q4 2021 haven't filed for Q1 2022 yet. Not filing isn't selling, so the changes leave them out.

New holders (28)

Institutions that held AbCellera Biologics Inc. at the end of Q1 2022 but not at the end of Q4 2021.

Institutions new to ABCL in Q1 2022
Institution	Shares	Value	% of portfolio
Polar Asset Management Partners Inc.	628,130	$6.12M	0.08%
Barclays PLC	248,070	$2.42M	0.00%
Voloridge Investment Management, LLC	129,882	$1.27M	0.01%
Schonfeld Strategic Advisors LLC	123,900	$1.21M	0.01%
Deutsche Bank AG	110,106	$1.07M	0.00%
HRT Financial LP	62,568	$610.0K	0.00%
Balyasny Asset Management LLC	62,339	$608.0K	0.00%
Erste Asset Management GmbH	62,000	$604.5K	0.01%
Y-Intercept (Hong Kong) Ltd	46,355	$452.0K	0.10%
Blueshift Asset Management, LLC	32,574	$318.0K	0.03%
Dynamic Technology Lab Private Ltd	31,427	$306.0K	0.04%
Acadian Asset Management LLC	29,123	$283.0K	0.00%
Bayesian Capital Management, LP	27,700	$270.0K	0.04%
Two Sigma Advisers, LP	24,400	$238.0K	0.00%
Fox Run Management, L.L.C.	24,366	$238.0K	0.13%
Corton Capital Inc.	23,680	$231.0K	0.10%
Tudor Investment Corp Et Al	21,109	$206.0K	0.01%
Cornerstone Investment Partners, LLC	19,025	$185.0K	0.01%
Belvedere Trading LLC	19,810	$172.0K	0.12%
Gsa Capital Partners LLP	16,988	$166.0K	0.02%
Delphia (USA) Inc.	16,348	$159.0K	0.12%
CTC Capital Management, LLC	16,000	$156.0K	0.42%
XTX Topco Ltd	14,040	$137.0K	0.06%
C M Bidwell & Associates Ltd	11,625	$113.0K	0.07%
Gryphon Financial Partners LLC	10,490	$102.0K	0.02%
SG3 Management, LLC	5,000	$49.0K	0.01%
Worth Asset Management, LLC	3,750	$25.0K	0.02%
Robbins Farley LLC	500	$5.00K	0.00%

Sold out (21)

Institutions that held AbCellera Biologics Inc. at the end of Q4 2021 and filed for Q1 2022 without it.

Institutions that sold out of ABCL in Q1 2022
Institution	Shares, Q4 2021	Value, Q4 2021
Swedbank AB	1,951,940	$28.0M
Capital International Inc	929,578	$13.3M
Jane Street Group, LLC	384,146	$5.49M
New York State Common Retirement Fund	158,847	$2.27M
BlueCrest Capital Management Ltd	143,307	$2.05M
Pentwater Capital Management LP	137,500	$1.97M
Alliancebernstein L.P.	125,000	$1.79M
Group One Trading, L.P.	84,531	$1.21M
Caption Management, LLC	70,700	$1.01M
FMR LLC	55,200	$789.0K
Gotham Asset Management, LLC	28,415	$406.0K
Graham Capital Management, L.P.	25,727	$367.0K
Scotia Capital Inc.	13,127	$188.0K
Moloney Securities Asset Management, LLC	13,100	$187.0K
Avidian Wealth Solutions, LLC	12,600	$180.0K
Quantamental Technologies LLC	12,080	$173.0K
Renaissance Capital LLC	10,327	$148.0K
Eagle Bay Advisors LLC	4,463	$85.0K
Spire Wealth Management	2,000	$29.0K
Migdal Insurance & Financial Holdings Ltd.	595	$9.00K
Bivin & Associates, Inc.	50	$1.00K

Not filed for Q1 2022 yet (1)

Institutions that held AbCellera Biologics Inc. at the end of Q4 2021 and haven't filed a 13F for Q1 2022. Not filing isn't selling, so they aren't counted as sold out.

Institutions holding ABCL in Q4 2021 that haven't filed for Q1 2022
Institution	Shares, Q4 2021	Value, Q4 2021
Reilly Financial Advisors, LLC	100	$1.00K